Patients with colorectal cancer were among the first to receive targeted therapies. These drugs aim to block the cancer-causing proteins that trigger out-of-control cell growth while sparing healthy tissues. But some patients ...
Dec 14, 2021
0
32
Restrictions in access to care during the COVID-19 pandemic caused disruptions in the treatment of cancer and other conditions. A new study now indicates that the pandemic also likely caused new cancer diagnoses to be delayed, ...
Dec 6, 2021
0
3
A new study has highlighted the prevalence of depression in bowel cancer patients up to five years after surgery to treat their cancer. Over a third of patients experienced clinically significant depression during the course ...
Dec 3, 2021
0
31
The National Comprehensive Cancer Network (NCCN) today announced the publication of new NCCN Guidelines for Patients: Colorectal Cancer Screening. Colorectal cancer (CRC) is the fourth most frequently diagnosed cancer in ...
Dec 1, 2021
0
5
(HealthDay)—Patients with psoriasis have an increased risk for colorectal cancer (CRC), according to a review published in the December issue of the Journal of the American Academy of Dermatology.
Nov 30, 2021
0
34
(HealthDay)—Greater adherence to a sulfur microbial diet is associated with an increased risk for colorectal cancer (CRC) in both men and women, according to a study published online Nov. 12 in JAMA Network Open.
Nov 24, 2021
0
2
Immune checkpoint inhibitors can boost the immune system's response to tumor cells, but the medications tend to be ineffective against certain cancers, especially colorectal and pancreatic cancers. A new clinical trial led ...
Nov 18, 2021
0
7
Black Americans are more likely to get colorectal cancer—and even more likely to die from the disease—than any other racial or ethnic group in the United States. And while Black people experience health disparities across ...
Nov 11, 2021
0
3
Exposure in utero to a drug used to prevent miscarriage can lead to an increased risk of developing cancer, according to researchers at The University of Texas Health Science Center at Houston (UTHealth Houston).
Nov 9, 2021
0
8
A parallel randomized controlled trial confirmed that a single flexible sigmoidoscopy screening at age 55 to 64 years represents a safe and effective strategy associated with a substantial reduction in colorectal cancer (CRC) ...
Nov 9, 2021
0
1
